Nath Bio-Genes (India) Financial Results
Nath Bio-Genes (India) Ltd reported consolidated annual revenue of ₹445.10 Crore for FY26. The Board recommended a dividend of ₹2 per share (20%) and approved the reappointment of Mr. Hitesh Rajnikant Purohit as an Independent Director for a second five-year term starting March 2027.
- Value
- ₹445.1 Cr